Michel et al., 2005 - Google Patents
Colonic infusion with Propionibacterium acidipropionici reduces severity of chemically-induced colitis in ratsMichel et al., 2005
View PDF- Document ID
- 4379818664185534587
- Author
- Michel C
- Roland N
- Lecannu G
- Hervé C
- Avice J
- Rival M
- Cherbut C
- Publication year
- Publication venue
- Le Lait
External Links
Snippet
Propionibacteria are cheese starters, also studied for their probiotic potential. An interesting feature is the ability of some strains to synthesize nitric oxide (NO) from nitrate reduction. NO production is hypothesized to be the mechanism by which some probiotics improve the …
- 241000700159 Rattus 0 title description 42
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/064—Saccharomycetales, e.g. baker's yeast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A23B - A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7483828B2 (en) | Treatment of Clostridium difficile infection | |
| US7846711B2 (en) | Lactobacillus strains and uses thereof | |
| US20160296570A1 (en) | Lactobacillus plantarum inducia dsm 21379 as enhancer of cellular immunity, hypocholesterolemic and anti-oxidative agent and antimicrobial agent against clostridium difficile | |
| Klayraung et al. | Antibacterial and antioxidant activities of acid and bile resistant strains of Lactobacillus fermentum isolated from miang | |
| Levit et al. | Evaluation of the effect of soymilk fermented by a riboflavin-producing Lactobacillus plantarum strain in a murine model of colitis | |
| JP2018536385A (en) | Novel lactic acid bacteria having various functions and uses thereof | |
| Corcionivoschi et al. | Probiotics-identification and ways of action | |
| EP2457575B1 (en) | New method for obtaining a Lactobacillus reuteri strain useful in medical and veterinary prophylaxis and treatment | |
| CN115778986A (en) | Use of fecal bacillus pulcherrimus and inert desulfurization vibrio for treating or preventing diabetes and intestinal diseases | |
| US20070071739A1 (en) | Treatment of bipolar disorder utilizing anti-fungal compositions | |
| CA2709850A1 (en) | Composition for human and/or animal nutrition, uses thereof and yeasts | |
| EP3808357A1 (en) | Composition and uses thereof | |
| Chaudhari et al. | In vitro and in vivo evaluation of probiotic potential and safety assessment of Bacillus coagulans SKB LAB-19 (MCC 0554) in humans and animal healthcare | |
| Strompfová et al. | Lactobacilli and enterococci—potential probiotics for dogs | |
| JP5740613B2 (en) | Disease prevention / improvement agent, endurance improver, anti-fatigue agent, and pharmaceuticals and foods and drinks using them | |
| JP6574815B2 (en) | Composition for preventing alopecia or promoting hair growth comprising a strain having lipolytic ability | |
| Michel et al. | Colonic infusion with Propionibacterium acidipropionici reduces severity of chemically-induced colitis in rats | |
| Samedi et al. | Evaluation of technological and probiotic abilities of local lactic acid bacteria | |
| JP2020022488A (en) | Novel lactic acid bacteria having various functionalities and application thereof | |
| AU650684B2 (en) | Antimicrobial composition | |
| JP4953824B2 (en) | Novel strain and fungus composition that imparts anti-pathogenicity to the host | |
| US11850270B2 (en) | Probiotics and methods of use | |
| US20220152126A1 (en) | Lactococcus lactis strains for the prevention and/or the treatment of visceral pain | |
| EP1487466A1 (en) | Use of lactobacillus farciminis for the prevention or pathology of digestive pathologies | |
| WO2019234076A1 (en) | New probiotic strain of lactobacillus brevis |